−1020KRW
−53.50 BKRW
11.26 BKRW
84.84 M
About NKMAX
Sector
Industry
CEO
Sang-Woo Park
Website
Headquarters
Seongnam
Employees (FY)
130
Founded
2002
ISIN
KR7182400002
FIGI
BBG00B09R3Y2
NKMAX Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. Its products include NK cells under NK Vue brand, recombinant proteins, and monoclonal antibodies. The company was founded on January 14, 2002 and is headquartered at Seongnam, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 182400 is 2020 KRW — it has increased by 9.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NKMAX stocks are traded under the ticker 182400.
182400 stock is 14.88% volatile and has beta coefficient of −0.20. Check out the list of the most volatile stocks — is NKMAX there?
Yes, you can track NKMAX financials in yearly and quarterly reports right on TradingView.
182400 net income for the last quarter is −41.26 B KRW, while the quarter before that showed −17.27 B KRW of net income which accounts for −138.85% change. Track more NKMAX financial stats to get the full picture.
Today NKMAX has the market capitalization of 172.74 B, it has decreased by 1.94% over the last week.
No, 182400 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 182400 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NKMAX stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 130.00 employees. See our rating of the largest employees — is NKMAX on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NKMAX technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NKMAX stock shows the sell signal. See more of NKMAX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NKMAX EBITDA is −47.26 B KRW, and current EBITDA margin is −356.48%. See more stats in NKMAX financial statements.